VIVA Biotech Holdings
HKEX:1873
VIVA Biotech Holdings
Net Income (Common)
VIVA Biotech Holdings
Net Income (Common) Peer Comparison
Competitive Net Income (Common) Analysis
Latest Figures & CAGR of Competitors
Company | Net Income (Common) | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
V
|
VIVA Biotech Holdings
HKEX:1873
|
Net Income (Common)
-¥116.1m
|
CAGR 3-Years
33%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
WuXi AppTec Co Ltd
SSE:603259
|
Net Income (Common)
¥9.6B
|
CAGR 3-Years
48%
|
CAGR 5-Years
34%
|
CAGR 10-Years
N/A
|
|
Pharmaron Beijing Co Ltd
SZSE:300759
|
Net Income (Common)
¥1.6B
|
CAGR 3-Years
11%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
WuXi Biologics (Cayman) Inc
HKEX:2269
|
Net Income (Common)
¥3.4B
|
CAGR 3-Years
26%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
|
Net Income (Common)
¥2B
|
CAGR 3-Years
5%
|
CAGR 5-Years
34%
|
CAGR 10-Years
36%
|
|
W
|
WuXi XDC Cayman Inc
HKEX:2268
|
Net Income (Common)
¥155.7m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is VIVA Biotech Holdings's Net Income (Common)?
Net Income (Common)
-116.1m
CNY
Based on the financial report for Dec 31, 2023, VIVA Biotech Holdings's Net Income (Common) amounts to -116.1m CNY.
What is VIVA Biotech Holdings's Net Income (Common) growth rate?
Net Income (Common) CAGR 3Y
33%
Over the last year, the Net Income (Common) growth was 78%. The average annual Net Income (Common) growth rates for VIVA Biotech Holdings have been 33% over the past three years .